Table 2.

Regression estimates for hemoglobin increments after RBC transfusion (N = 6220)

CharacteristicHemoglobin increment (95% CI), g/dL P value
Donor metabolite characteristics   
Hypoxanthine –0.10 (–0.18 to –0.02) .01 
HETE –0.03 (–0.07 to 0.01) .13 
Urate –0.05 (–0.12 to –0.01) .04 
l-Citrulline 0.05 (0.01-0.12) .04 
Donor genetic characteristics   
SLC7A5 (kynurenine: RS8052118) –0.09 (–0.17 to 0.01) .04 
P53 (HETE: RS80649467) –0.13 (–0.22 to –0.04) .01 
ABCG2 (urate: RS138409370) –0.13 (–0.29 to –0.03) .04 
Irradiation + PFKP (hypoxanthine: RS2388595) –0.15 (–0.27 to –0.03) .01 
CharacteristicHemoglobin increment (95% CI), g/dL P value
Donor metabolite characteristics   
Hypoxanthine –0.10 (–0.18 to –0.02) .01 
HETE –0.03 (–0.07 to 0.01) .13 
Urate –0.05 (–0.12 to –0.01) .04 
l-Citrulline 0.05 (0.01-0.12) .04 
Donor genetic characteristics   
SLC7A5 (kynurenine: RS8052118) –0.09 (–0.17 to 0.01) .04 
P53 (HETE: RS80649467) –0.13 (–0.22 to –0.04) .01 
ABCG2 (urate: RS138409370) –0.13 (–0.29 to –0.03) .04 
Irradiation + PFKP (hypoxanthine: RS2388595) –0.15 (–0.27 to –0.03) .01 

Multivariable regression estimates estimating the mean hemoglobin increment after transfusion with 95% CIs accounting for the blood donor, product, and transfusion recipient covariates in Table 1.

or Create an Account

Close Modal
Close Modal